{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:33:39Z","timestamp":1782948819892,"version":"3.54.5"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS080967"],"award-info":[{"award-number":["R01NS080967"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG069941"],"award-info":[{"award-number":["RF1AG069941"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R21AG085473"],"award-info":[{"award-number":["R21AG085473"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CUIMC TIGER grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>APOE4<\/jats:italic>\n                    is the leading genetic risk factor for Alzheimer\u2019s disease, and chronic stress is a leading environmental risk factor. Studies suggest that\n                    <jats:italic>APOE4<\/jats:italic>\n                    confers vulnerability to the behavioral and neuropathological effects of chronic stress, representing a potential mechanism by which this genetic variant accelerates Alzheimer\u2019s onset and progression. Whether and how\n                    <jats:italic>APOE4<\/jats:italic>\n                    -mediated stress vulnerability manifests in neurons of the hippocampus, a brain region particularly susceptible to stress and Alzheimer\u2019s pathology, remains unexplored. Using a combination of in vivo and in vitro experiments in humanized\n                    <jats:italic>APOE4<\/jats:italic>\n                    and\n                    <jats:italic>APOE3<\/jats:italic>\n                    knockin mice and primary hippocampal neurons from these animals, we investigated whether and how\n                    <jats:italic>APOE4<\/jats:italic>\n                    confers sensitivity to glucocorticoids (GCs), the main stress hormones. We found that a hallmark of stress\/GC-induced brain damage, tau pathology (i.e., tau accumulation, hyperphosphorylation, and spreading) is exacerbated in\n                    <jats:italic>APOE4<\/jats:italic>\n                    versus\n                    <jats:italic>APOE3<\/jats:italic>\n                    mice. Moreover,\n                    <jats:italic>APOE4<\/jats:italic>\n                    animals exhibit underlying mitochondrial dysfunction and enhanced glucocorticoid receptor activation in the hippocampus, factors that likely contribute to tau pathogenesis in both the presence and absence of stress\/GCs. Supporting this concept, opening of the mitochondrial permeability transition pore (mPTP) drives mitochondrial dysfunction and tau pathology in\n                    <jats:italic>APOE4<\/jats:italic>\n                    mice, while pharmacological inhibition of the mPTP is protective against ApoE4-mediated mitochondrial damage, tau phosphorylation and spreading, and downstream hippocampal synapse loss. These findings shed light on the mechanisms of stress vulnerability in\n                    <jats:italic>APOE4<\/jats:italic>\n                    carriers and identify the mPTP as a potential therapeutic target for ameliorating Alzheimer\u2019s pathogenesis in this population.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08543-1","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:24:46Z","timestamp":1774646686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["APOE4 exacerbates glucocorticoid stress hormone-induced tau pathology via mitochondrial dysfunction"],"prefix":"10.1038","volume":"17","author":[{"given":"Qing","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veria","family":"Puerta-Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6001-8040","authenticated-orcid":false,"given":"Jeffrey H.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4263-5576","authenticated-orcid":false,"given":"Clarissa L.","family":"Waites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"8543_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021;20:68\u201380.","journal-title":"Lancet Neurol"},{"key":"8543_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10571-017-0521-1","volume":"38","author":"B Mravec","year":"2018","unstructured":"Mravec B, Horvathova L, Padova A. Brain under stress and Alzheimer\u2019s disease. Cell Mol Neurobiol. 2018;38:73\u201384.","journal-title":"Cell Mol Neurobiol"},{"key":"8543_CR3","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3389\/fphar.2019.00976","volume":"10","author":"A Caruso","year":"2019","unstructured":"Caruso A, Nicoletti F, Gaetano A, Scaccianoce S. Risk factors for Alzheimer\u2019s disease: focus on stress. Front Pharm. 2019;10:976.","journal-title":"Front Pharm"},{"key":"8543_CR4","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.tins.2024.08.015","volume":"47","author":"MR Burke","year":"2024","unstructured":"Burke MR, Sotiropoulos I, Waites CL. The multiple roles of chronic stress and glucocorticoids in Alzheimer\u2019s disease pathogenesis. Trends Neurosci. 2024;47:933\u201348.","journal-title":"Trends Neurosci"},{"key":"8543_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1515\/revneuro-2014-0035","volume":"25","author":"A Machado","year":"2014","unstructured":"Machado A, Herrera AJ, de Pablos RM, Espinosa-Oliva AM, Sarmiento M, Ayala A, et al. Chronic stress as a risk factor for Alzheimer\u2019s disease. Rev Neurosci. 2014;25:785\u2013804.","journal-title":"Rev Neurosci"},{"key":"8543_CR6","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1093\/brain\/awq116","volume":"133","author":"L Johansson","year":"2010","unstructured":"Johansson L, Guo X, Waern M, Ostling S, Gustafson D, Bengtsson C, et al. Midlife psychological stress and risk of dementia: a 35-year longitudinal population study. Brain. 2010;133:2217\u201324.","journal-title":"Brain"},{"key":"8543_CR7","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jocn.2008.12.026","volume":"16","author":"CW Huang","year":"2009","unstructured":"Huang CW, Lui CC, Chang WN, Lu CH, Wang YL, Chang CC. Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer\u2019s disease. J Clin Neurosci. 2009;16:1283\u20136.","journal-title":"J Clin Neurosci"},{"key":"8543_CR8","doi-asserted-by":"publisher","first-page":"e1003016","DOI":"10.1371\/journal.pmed.1003016","volume":"17","author":"S Holmquist","year":"2020","unstructured":"Holmquist S, Nordstrom A, Nordstrom P. The association of depression with subsequent dementia diagnosis: a Swedish nationwide cohort study from 1964 to 2016. PLoS Med. 2020;17:e1003016.","journal-title":"PLoS Med"},{"key":"8543_CR9","doi-asserted-by":"crossref","unstructured":"Saiz-Vazquez O, Gracia-Garcia P, Ubillos-Landa S, Puente-Martinez A, Casado-Yusta S, Olaya B, et al. Depression as a risk factor for Alzheimer\u2019s disease: a systematic review of longitudinal meta-analyses. J Clin Med. 2021;10:1809.","DOI":"10.3390\/jcm10091809"},{"key":"8543_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.pnpbp.2007.09.023","volume":"32","author":"YC Yen","year":"2008","unstructured":"Yen YC, Rebok GW, Yang MJ, Lung FW. A multilevel analysis of the influence of Apolipoprotein E genotypes on depressive symptoms in late-life moderated by the environment. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:479\u201386.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8543_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/JGP.0b013e3180f63373","volume":"15","author":"YC Yen","year":"2007","unstructured":"Yen YC, Rebok GW, Gallo JJ, Yang MJ, Lung FW, Shih CH. ApoE4 allele is associated with late-life depression: a population-based study. Am J Geriatr Psychiatry. 2007;15:858\u201368.","journal-title":"Am J Geriatr Psychiatry"},{"key":"8543_CR12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jagp.2016.08.007","volume":"24","author":"SE Holmes","year":"2016","unstructured":"Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, et al. beta-Amyloid, APOE and BDNF genotype, and depressive and anxiety symptoms in cognitively normal older women and men. Am J Geriatr Psychiatry. 2016;24:1191\u20135.","journal-title":"Am J Geriatr Psychiatry"},{"key":"8543_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12944-016-0288-2","volume":"15","author":"J Dose","year":"2016","unstructured":"Dose J, Huebbe P, Nebel A, Rimbach G. APOE genotype and stress response\u2014a mini review. Lipids Health Dis. 2016;15:121.","journal-title":"Lipids Health Dis"},{"key":"8543_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.biopsych.2007.03.013","volume":"62","author":"GM Peavy","year":"2007","unstructured":"Peavy GM, Lange KL, Salmon DP, Patterson TL, Goldman S, Gamst AC, et al. The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biol Psychiatry. 2007;62:472\u20138.","journal-title":"Biol Psychiatry"},{"key":"8543_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-981-32-9358-8_20","volume":"1184","author":"I Sotiropoulos","year":"2019","unstructured":"Sotiropoulos I, Silva JM, Gomes P, Sousa N, Almeida OFX. Stress and the etiopathogenesis of Alzheimer\u2019s disease and depression. Adv Exp Med Biol. 2019;1184:241\u201357.","journal-title":"Adv Exp Med Biol"},{"key":"8543_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol Neurodegener. 2020;15:30.","journal-title":"Mol Neurodegener"},{"key":"8543_CR17","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.1093\/brain\/awad127","volume":"146","author":"F Du","year":"2023","unstructured":"Du F, Yu Q, Swerdlow RH, Waites CL. Glucocorticoid-driven mitochondrial damage stimulates Tau pathology. Brain. 2023;146:4378\u201394.","journal-title":"Brain"},{"key":"8543_CR18","doi-asserted-by":"publisher","first-page":"e2404","DOI":"10.1212\/WNL.0000000000009582","volume":"94","author":"J Yin","year":"2020","unstructured":"Yin J, Reiman EM, Beach TG, Serrano GE, Sabbagh MN, Nielsen M, et al. Effect of ApoE isoforms on mitochondria in Alzheimer disease. Neurology. 2020;94:e2404\u2013e11.","journal-title":"Neurology"},{"key":"8543_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3233\/JAD-190074","volume":"70","author":"S Simonovitch","year":"2019","unstructured":"Simonovitch S, Schmukler E, Masliah E, Pinkas-Kramarski R, Michaelson DM. The effects of APOE4 on mitochondrial dynamics and proteins in vivo. J Alzheimers Dis. 2019;70:861\u201375.","journal-title":"J Alzheimers Dis"},{"key":"8543_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01631-0","volume":"11","author":"W Fang","year":"2021","unstructured":"Fang W, Xiao N, Zeng G, Bi D, Dai X, Mi X, et al. APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline. Transl Psychiatry. 2021;11:507.","journal-title":"Transl Psychiatry"},{"key":"8543_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02776-4","volume":"11","author":"E Schmukler","year":"2020","unstructured":"Schmukler E, Solomon S, Simonovitch S, Goldshmit Y, Wolfson E, Michaelson DM, et al. Altered mitochondrial dynamics and function in APOE4-expressing astrocytes. Cell Death Dis. 2020;11:578.","journal-title":"Cell Death Dis"},{"key":"8543_CR22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549:523\u20137.","journal-title":"Nature"},{"key":"8543_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s43587-023-00368-3","volume":"3","author":"N Koutsodendris","year":"2023","unstructured":"Koutsodendris N, Blumenfeld J, Agrawal A, Traglia M, Grone B, Zilberter M, et al. Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits. Nat Aging. 2023;3:275\u201396.","journal-title":"Nat Aging"},{"key":"8543_CR24","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. 2021;109:1657\u201374.e7.","journal-title":"Neuron"},{"key":"8543_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.838436","volume":"14","author":"KE Foley","year":"2022","unstructured":"Foley KE, Hewes AA, Garceau DT, Kotredes KP, Carter GW, Sasner M, et al. The APOE (epsilon3\/epsilon4) genotype drives distinct gene signatures in the cortex of young mice. Front Aging Neurosci. 2022;14:838436.","journal-title":"Front Aging Neurosci"},{"key":"8543_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1101\/lm.053588.122","volume":"29","author":"JW McLean","year":"2022","unstructured":"McLean JW, Bhattrai A, Vitali F, Raikes AC, Wiegand JL, Brinton RD. Contributions of sex and genotype to exploratory behavior differences in an aged humanized APOE mouse model of late-onset Alzheimer\u2019s disease. Learn Mem. 2022;29:321\u201331.","journal-title":"Learn Mem"},{"key":"8543_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53:337\u201351.","journal-title":"Neuron"},{"key":"8543_CR28","doi-asserted-by":"publisher","first-page":"73.","DOI":"10.1038\/s41419-024-06458-3","volume":"15","author":"Q Yu","year":"2024","unstructured":"Yu Q, Du F, Belli I, Gomes PA, Sotiropoulos I, Waites CL. Glucocorticoid stress hormones stimulate vesicle-free Tau secretion and spreading in the brain. Cell Death Dis. 2024;15:73.","journal-title":"Cell Death Dis"},{"key":"8543_CR29","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1093\/brain\/awx258","volume":"140","author":"F Du","year":"2017","unstructured":"Du F, Yu Q, Yan S, Hu G, Lue LF, Walker DG, et al. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer\u2019s disease. Brain. 2017;140:3233\u201351.","journal-title":"Brain"},{"key":"8543_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3233\/JAD-150917","volume":"51","author":"D Fang","year":"2016","unstructured":"Fang D, Zhang Z, Li H, Yu Q, Douglas JT, Bratasz A, et al. Increased electron paramagnetic resonance signal correlates with mitochondrial dysfunction and oxidative stress in an Alzheimer\u2019s disease mouse brain. J Alzheimers Dis. 2016;51:571\u201380.","journal-title":"J Alzheimers Dis"},{"key":"8543_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch JN, Luna G, Guzman E, Audouard M, Challis C, Sibih YE, et al. LRP1 is a master regulator of tau uptake and spread. Nature. 2020;580:381\u20135.","journal-title":"Nature"},{"key":"8543_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw6404","volume":"5","author":"S Wegmann","year":"2019","unstructured":"Wegmann S, Bennett RE, Delorme L, Robbins AB, Hu M, McKenzie D, et al. Experimental evidence for the age dependence of tau protein spread in the brain. Sci Adv. 2019;5:eaaw6404.","journal-title":"Sci Adv"},{"key":"8543_CR33","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/s41593-021-00851-3","volume":"24","author":"KA Zalocusky","year":"2021","unstructured":"Zalocusky KA, Najm R, Taubes AL, Hao Y, Yoon SY, Koutsodendris N, et al. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer\u2019s disease. Nat Neurosci. 2021;24:786\u201398.","journal-title":"Nat Neurosci"},{"key":"8543_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42:293\u2013304.","journal-title":"Nat Biotechnol"},{"key":"8543_CR35","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nbt.2931","volume":"32","author":"D Risso","year":"2014","unstructured":"Risso D, Ngai J, Speed TP, Dudoit S. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat Biotechnol. 2014;32:896\u2013902.","journal-title":"Nat Biotechnol"},{"key":"8543_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"8543_CR37","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36:2628\u20139.","journal-title":"Bioinformatics"},{"key":"8543_CR38","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1139\/Y09-027","volume":"87","author":"JM You","year":"2009","unstructured":"You JM, Yun SJ, Nam KN, Kang C, Won R, Lee EH. Mechanism of glucocorticoid-induced oxidative stress in rat hippocampal slice cultures. Can J Physiol Pharm. 2009;87:440\u20137.","journal-title":"Can J Physiol Pharm"},{"key":"8543_CR39","doi-asserted-by":"crossref","unstructured":"Vaz-Silva J, Gomes P, Jin Q, Zhu M, Zhuravleva V, Quintremil S, et al. Endolysosomal degradation of Tau and its role in glucocorticoid-driven hippocampal malfunction. EMBO J. 2018;37:EMBJ201899084.","DOI":"10.15252\/embj.201899084"},{"key":"8543_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108972","volume":"110","author":"L Yang","year":"2022","unstructured":"Yang L, Zhou H, Huang L, Su Y, Kong L, Ji P, et al. Stress level of glucocorticoid exacerbates neuronal damage and Abeta production through activating NLRP1 inflammasome in primary cultured hippocampal neurons of APP-PS1 mice. Int Immunopharmacol. 2022;110:108972.","journal-title":"Int Immunopharmacol"},{"key":"8543_CR41","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1471-4159.2008.05613.x","volume":"107","author":"I Sotiropoulos","year":"2008","unstructured":"Sotiropoulos I, Catania C, Riedemann T, Fry JP, Breen KC, Michaelidis TM, et al. Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau. J Neurochem. 2008;107:385\u201397.","journal-title":"J Neurochem"},{"key":"8543_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61142-8","volume":"10","author":"E Area-Gomez","year":"2020","unstructured":"Area-Gomez E, Larrea D, Pera M, Agrawal RR, Guilfoyle DN, Pirhaji L, et al. APOE4 is associated with differential regional vulnerability to bioenergetic deficits in aged APOE mice. Sci Rep. 2020;10:4277.","journal-title":"Sci Rep"},{"key":"8543_CR43","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/j.celrep.2018.10.078","volume":"25","author":"M Merezhko","year":"2018","unstructured":"Merezhko M, Brunello CA, Yan X, Vihinen H, Jokitalo E, Uronen RL, et al. Secretion of Tau via an unconventional non-vesicular mechanism. Cell Rep. 2018;25:2027\u201335.e4.","journal-title":"Cell Rep"},{"key":"8543_CR44","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.celrep.2018.04.056","volume":"23","author":"T Katsinelos","year":"2018","unstructured":"Katsinelos T, Zeitler M, Dimou E, Karakatsani A, Muller HM, Nachman E, et al. Unconventional secretion mediates the trans-cellular spreading of Tau. Cell Rep. 2018;23:2039\u201355.","journal-title":"Cell Rep"},{"key":"8543_CR45","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3233\/JAD-181184","volume":"68","author":"AL Orr","year":"2019","unstructured":"Orr AL, Kim C, Jimenez-Morales D, Newton BW, Johnson JR, Krogan NJ, et al. Neuronal apolipoprotein E4 expression results in proteome-wide alterations and compromises bioenergetic capacity by disrupting mitochondrial function. J Alzheimers Dis. 2019;68:991\u20131011.","journal-title":"J Alzheimers Dis"},{"key":"8543_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108572","volume":"34","author":"G Qi","year":"2021","unstructured":"Qi G, Mi Y, Shi X, Gu H, Brinton RD, Yin F. ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism. Cell Rep. 2021;34:108572.","journal-title":"Cell Rep"},{"key":"8543_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2023.102684","volume":"79","author":"RW Mahley","year":"2023","unstructured":"Mahley RW. Apolipoprotein E4 targets mitochondria and the mitochondria-associated membrane complex in neuropathology, including Alzheimer\u2019s disease. Curr Opin Neurobiol. 2023;79:102684.","journal-title":"Curr Opin Neurobiol"},{"key":"8543_CR48","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","volume":"132","author":"RH Oakley","year":"2013","unstructured":"Oakley RH, Cidlowski JA. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol. 2013;132:1033\u201344.","journal-title":"J Allergy Clin Immunol"},{"key":"8543_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67645-8","volume":"10","author":"A Kaziales","year":"2020","unstructured":"Kaziales A, Barkovits K, Marcus K, Richter K. Glucocorticoid receptor complexes form cooperatively with the Hsp90 co-chaperones Pp5 and FKBPs. Sci Rep. 2020;10:10733.","journal-title":"Sci Rep"},{"key":"8543_CR50","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.cell.2014.04.038","volume":"157","author":"E Kirschke","year":"2014","unstructured":"Kirschke E, Goswami D, Southworth D, Griffin PR, Agard DA. Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles. Cell. 2014;157:1685\u201397.","journal-title":"Cell"},{"key":"8543_CR51","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-021-00433-y","volume":"23","author":"M Bonora","year":"2022","unstructured":"Bonora M, Giorgi C, Pinton P. Molecular mechanisms and consequences of mitochondrial permeability transition. Nat Rev Mol Cell Biol. 2022;23:266\u201385.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8543_CR52","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nprot.2016.064","volume":"11","author":"M Bonora","year":"2016","unstructured":"Bonora M, Morganti C, Morciano G, Giorgi C, Wieckowski MR, Pinton P. Comprehensive analysis of mitochondrial permeability transition pore activity in living cells using fluorescence-imaging-based techniques. Nat Protoc. 2016;11:1067\u201380.","journal-title":"Nat Protoc"},{"key":"8543_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101594","volume":"59","author":"S Parhizkar","year":"2022","unstructured":"Parhizkar S, Holtzman DM. APOE mediated neuroinflammation and neurodegeneration in Alzheimer\u2019s disease. Semin Immunol. 2022;59:101594.","journal-title":"Semin Immunol"},{"key":"8543_CR54","first-page":"277","volume":"11","author":"C Koriath","year":"2019","unstructured":"Koriath C, Lashley T, Taylor W, Druyeh R, Dimitriadis A, Denning N, et al. ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-beta copathology. Alzheimers Dement. 2019;11:277\u201380.","journal-title":"Alzheimers Dement"},{"key":"8543_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M, Zhang M, Yin X, Chen K, Hu Z, Zhou Q, et al. The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Transl Neurodegener. 2021;10:45.","journal-title":"Transl Neurodegener"},{"key":"8543_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6391686","volume":"2016","author":"S Vyas","year":"2016","unstructured":"Vyas S, Rodrigues AJ, Silva JM, Tronche F, Almeida OF, Sousa N, et al. Chronic stress and glucocorticoids: from neuronal plasticity to neurodegeneration. Neural Plasticity. 2016;2016:6391686.","journal-title":"Neural Plasticity"},{"key":"8543_CR57","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamaneurol.2023.4038","volume":"80","author":"A Steward","year":"2023","unstructured":"Steward A, Biel D, Dewenter A, Roemer S, Wagner F, Dehsarvi A, et al. ApoE4 and connectivity-mediated spreading of tau pathology at lower amyloid levels. JAMA Neurol. 2023;80:1295\u2013306.","journal-title":"JAMA Neurol"},{"key":"8543_CR58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2108870119","volume":"119","author":"SR Saroja","year":"2022","unstructured":"Saroja SR, Gorbachev K, Julia T, Goate AM, Pereira AC. Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation. Proc Natl Acad Sci USA. 2022;119:e2108870119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8543_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0107-2","volume":"11","author":"LY Lin","year":"2016","unstructured":"Lin LY, Zhang J, Dai XM, Xiao NA, Wu XL, Wei Z, et al. Early-life stress leads to impaired spatial learning and memory in middle-aged ApoE4-TR mice. Mol Neurodegener. 2016;11:51.","journal-title":"Mol Neurodegener"},{"key":"8543_CR60","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/gerona\/glr106","volume":"66","author":"Y Zeng","year":"2011","unstructured":"Zeng Y, Hughes CL, Lewis MA, Li J, Zhang F. Interactions between life stress factors and carrying the APOE4 allele adversely impact self-reported health in old adults. J Gerontol A Biol Sci Med Sci. 2011;66:1054\u201361.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"8543_CR61","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jpsychires.2021.09.029","volume":"143","author":"J Zhang","year":"2021","unstructured":"Zhang J, Lin L, Dai X, Xiao N, Ye Q, Chen X. ApoE4 increases susceptibility to stress-induced age-dependent depression-like behavior and cognitive impairment. J Psychiatr Res. 2021;143:292\u2013301.","journal-title":"J Psychiatr Res"},{"key":"8543_CR62","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00018-022-04516-7","volume":"79","author":"J Rueter","year":"2022","unstructured":"Rueter J, Rimbach G, Huebbe P. Functional diversity of apolipoprotein E: from subcellular localization to mitochondrial function. Cell Mol Life Sci. 2022;79:499.","journal-title":"Cell Mol Life Sci"},{"key":"8543_CR63","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s11064-018-2629-1","volume":"44","author":"SS Munoz","year":"2019","unstructured":"Munoz SS, Garner B, Ooi L. Understanding the role of ApoE fragments in Alzheimer\u2019s disease. Neurochem Res. 2019;44:1297\u2013305.","journal-title":"Neurochem Res"},{"key":"8543_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-4-35","volume":"4","author":"T Nakamura","year":"2009","unstructured":"Nakamura T, Watanabe A, Fujino T, Hosono T, Michikawa M. Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells. Mol Neurodegener. 2009;4:35.","journal-title":"Mol Neurodegener"},{"key":"8543_CR65","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13578-021-00563-y","volume":"11","author":"T Liang","year":"2021","unstructured":"Liang T, Hang W, Chen J, Wu Y, Wen B, Xu K, et al. ApoE4 (Delta272-299) induces mitochondrial-associated membrane formation and mitochondrial impairment by enhancing GRP75-modulated mitochondrial calcium overload in neuron. Cell Biosci. 2021;11:50.","journal-title":"Cell Biosci"},{"key":"8543_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154227","volume":"107","author":"WY Chen","year":"2020","unstructured":"Chen WY, Chen YF, Chan HC, Chung CH, Peng HY, Ho YC, et al. Role of apolipoprotein E in electronegative low-density lipoprotein-induced mitochondrial dysfunction in cardiomyocytes. Metabolism. 2020;107:154227.","journal-title":"Metabolism"},{"key":"8543_CR67","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41388-023-02907-z","volume":"43","author":"FR Palma","year":"2024","unstructured":"Palma FR, Gantner BN, Sakiyama MJ, Kayzuka C, Shukla S, Lacchini R, et al. ROS production by mitochondria: function or dysfunction?. Oncogene. 2024;43:295\u2013303.","journal-title":"Oncogene"},{"key":"8543_CR68","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.cell.2025.12.038","volume":"189","author":"AJ Samelson","year":"2026","unstructured":"Samelson AJ, Ariqat N, McKetney J, Rohanitazangi G, Bravo CP, Bose R. CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis. Cell. 2026;189:1517\u20131534.e19.","journal-title":"Cell"},{"key":"8543_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27572-2","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Tapias V, Acosta D, Xu H, Chen H, Bhawal R, et al. Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer\u2019s disease. Nat Commun. 2022;13:159.","journal-title":"Nat Commun"},{"key":"8543_CR70","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1126\/science.aaf6846","volume":"356","author":"A Patel","year":"2017","unstructured":"Patel A, Malinovska L, Saha S, Wang J, Alberti S, Krishnan Y, et al. ATP as a biological hydrotrope. Science. 2017;356:753\u20136.","journal-title":"Science"},{"key":"8543_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09107-y","volume":"10","author":"S Sridharan","year":"2019","unstructured":"Sridharan S, Kurzawa N, Werner T, Gunthner I, Helm D, Huber W, et al. Proteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP. Nat Commun. 2019;10:1155.","journal-title":"Nat Commun"},{"key":"8543_CR72","doi-asserted-by":"publisher","unstructured":"Lai R-HC, R-H, Hsu, PW-C, Chen, Y-C, Lam, K-H, Pai, W-Y, Juang, J-L. Early Alzheimer\u2019s brain atrophy in entorhinal cortex is associated with HSD11B1-cortisol axis in APOE4 carriers. Res Square. 2025. https:\/\/doi.org\/10.21203\/rs.3.rs-6011135\/v1.","DOI":"10.21203\/rs.3.rs-6011135\/v1"},{"key":"8543_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/frdem.2023.1320329","volume":"2","author":"K Sato","year":"2023","unstructured":"Sato K, Niimi Y, Ihara R, Suzuki K, Iwata A, Iwatsubo T. APOE-epsilon4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer\u2019s disease: implications for anti-amyloid beta therapy. Front Dement. 2023;2:1320329.","journal-title":"Front Dement"},{"key":"8543_CR74","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fnins.2018.00441","volume":"12","author":"MJ Perez","year":"2018","unstructured":"Perez MJ, Jara C, Quintanilla RA. Contribution of tau pathology to mitochondrial impairment in neurodegeneration. Front Neurosci. 2018;12:441.","journal-title":"Front Neurosci"},{"key":"8543_CR75","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nm.1868","volume":"14","author":"H Du","year":"2008","unstructured":"Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer\u2019s disease. Nat Med. 2008;14:1097\u2013105.","journal-title":"Nat Med"},{"key":"8543_CR76","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/brain\/awad432","volume":"147","author":"S Samanta","year":"2024","unstructured":"Samanta S, Akhter F, Roy A, Chen D, Turner B, Wang Y, et al. New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer\u2019s disease. Brain. 2024;147:1710\u201325.","journal-title":"Brain"},{"key":"8543_CR77","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","volume":"183","author":"CH Yu","year":"2020","unstructured":"Yu CH, Davidson S, Harapas CR, Hilton JB, Mlodzianoski MJ, Laohamonthonkul P, et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS. Cell. 2020;183:636\u201349.e18.","journal-title":"Cell"},{"key":"8543_CR78","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","volume":"55","author":"H Xian","year":"2022","unstructured":"Xian H, Watari K, Sanchez-Lopez E, Offenberger J, Onyuru J, Sampath H, et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022;55:1370\u201385.e8.","journal-title":"Immunity"},{"key":"8543_CR79","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"S Marchi","year":"2023","unstructured":"Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L. Mitochondrial control of inflammation. Nat Rev Immunol. 2023;23:159\u201373.","journal-title":"Nat Rev Immunol"},{"key":"8543_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107420","volume":"93","author":"Q Gui","year":"2021","unstructured":"Gui Q, Jiang Z, Zhang L. Insights into the modulatory role of cyclosporine A and its research advances in acute inflammation. Int Immunopharmacol. 2021;93:107420.","journal-title":"Int Immunopharmacol"},{"key":"8543_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2024.106994","volume":"205","author":"F Guareschi","year":"2025","unstructured":"Guareschi F, Fonseca C, Silva S, Pescina S, Nicoli S, Buttini F, et al. Therapeutic effect of cyclosporine A-loading TPGS micelles on a mouse model of LPS-induced neuroinflammation. Eur J Pharm Sci. 2025;205:106994.","journal-title":"Eur J Pharm Sci"},{"key":"8543_CR82","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1089\/ars.2016.6905","volume":"27","author":"M Langley","year":"2017","unstructured":"Langley M, Ghosh A, Charli A, Sarkar S, Ay M, Luo J, et al. Mito-apocynin prevents mitochondrial dysfunction, microglial activation, oxidative damage, and progressive neurodegeneration in MitoPark transgenic mice. Antioxid Redox Signal. 2017;27:1048\u201366.","journal-title":"Antioxid Redox Signal"},{"key":"8543_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.612554","volume":"9","author":"N Liu","year":"2021","unstructured":"Liu N, Lin MM, Huang SS, Liu ZQ, Wu JC, Liang ZQ, et al. NADPH and mito-apocynin treatment protects against KA-induced excitotoxic injury through autophagy pathway. Front Cell Dev Biol. 2021;9:612554.","journal-title":"Front Cell Dev Biol"},{"key":"8543_CR84","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11481-016-9650-4","volume":"11","author":"A Ghosh","year":"2016","unstructured":"Ghosh A, Langley MR, Harischandra DS, Neal ML, Jin H, Anantharam V, et al. Mitoapocynin treatment protects against neuroinflammation and dopaminergic neurodegeneration in a preclinical animal model of Parkinson\u2019s disease. J Neuroimmune Pharm. 2016;11:259\u201378.","journal-title":"J Neuroimmune Pharm"},{"key":"8543_CR85","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neulet.2014.09.042","volume":"583","author":"BP Dranka","year":"2014","unstructured":"Dranka BP, Gifford A, McAllister D, Zielonka J, Joseph J, O\u2019Hara CL, et al. A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson\u2019s disease. Neurosci Lett. 2014;583:159\u201364.","journal-title":"Neurosci Lett"},{"key":"8543_CR86","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2009.03.003","volume":"32","author":"H Du","year":"2011","unstructured":"Du H, Guo L, Zhang W, Rydzewska M, Yan S. Cyclophilin D deficiency improves mitochondrial function and learning\/memory in aging Alzheimer disease mouse model. Neurobiol Aging. 2011;32:398\u2013406.","journal-title":"Neurobiol Aging"},{"key":"8543_CR87","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1074\/jbc.M115.700385","volume":"291","author":"J Warne","year":"2016","unstructured":"Warne J, Pryce G, Hill JM, Shi X, Lenneras F, Puentes F, et al. Selective inhibition of the mitochondrial permeability transition pore protects against neurodegeneration in experimental multiple sclerosis. J Biol Chem. 2016;291:4356\u201373.","journal-title":"J Biol Chem"},{"key":"8543_CR88","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.tiv.2015.01.003","volume":"30","author":"P Bellwon","year":"2015","unstructured":"Bellwon P, Culot M, Wilmes A, Schmidt T, Zurich MG, Schultz L, et al. Cyclosporine A kinetics in brain cell cultures and its potential of crossing the blood-brain barrier. Toxicol Vitr. 2015;30:166\u201375.","journal-title":"Toxicol Vitr"},{"key":"8543_CR89","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/med.21892","volume":"42","author":"A Haleckova","year":"2022","unstructured":"Haleckova A, Benek O, Zemanova L, Dolezal R, Musilek K. Small-molecule inhibitors of cyclophilin D as potential therapeutics in mitochondria-related diseases. Med Res Rev. 2022;42:1822\u201355.","journal-title":"Med Res Rev"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08543-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08543-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08543-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:04:01Z","timestamp":1778148241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08543-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8543"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08543-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"419"}}